AVEFF (Avecho Biotechnology) Buyback Yield % : 0.00 (As of Apr. 19, 2025)

View and export this data going back to 2006. Start your Free Trial

What is Avecho Biotechnology Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Avecho Biotechnology's current buyback yield was 0.00%.

Avecho Biotechnology Buyback Yield % Historical Data

The historical data trend for Avecho Biotechnology's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avecho Biotechnology Buyback Yield % Chart

Avecho Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-37.13

-0.01

-769.41

Avecho Biotechnology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															-0.01	-16.98	-65.69	-57.34	-

Competitive Comparison of Avecho Biotechnology's Buyback Yield %

For the Biotechnology subindustry, Avecho Biotechnology's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avecho Biotechnology's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Avecho Biotechnology Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Avecho Biotechnology's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	0)	/	3.8031564
	=	0.00%

Avecho Biotechnology's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	0)		/	3.8031564
	=	0.00%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Avecho Biotechnology Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Avecho Biotechnology's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avecho Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avecho Biotechnology Ltd (OTCPK:AVEFF) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

OEZ:Germany AVE:Australia

Address

Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168

Website

https://www.avecho.com.au

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Avecho Biotechnology Headlines

From GuruFocus

Avecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in Australia

By PRNewswire • 03-03-2025